메뉴 건너뛰기
Brenner's Encyclopedia of Genetics: Second Edition
Volumn , Issue , 2013, Pages 36-38
Advanced Glycation End-Products
Author keywords

Cardiovascular disease; Diabetes; Hyperglycemia; Oxidative stress; RAGE
Indexed keywords

EID: 85016574413     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374984-0.00476-9     Document Type: Chapter
Times cited : (7)
References (9)
  • 1
    • 23744505354 scopus 로고    scopus 로고
    • Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes
    • Cameron N.E., Gibson T.M., Nangle M.R., Cotter M.A. Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes. Annals of the New York Academy of Sciences 2005, 1043:784-792.
    • (2005) Annals of the New York Academy of Sciences , vol.1043 , pp. 784-792
    • Cameron, N.E.1    Gibson, T.M.2    Nangle, M.R.3    Cotter, M.A.4
  • 2
    • 78649664499 scopus 로고    scopus 로고
    • Metformin use and mortality among patients with diabetes and atherothrombosis
    • Roussel R., Travert F., Pasquet B., et al. Metformin use and mortality among patients with diabetes and atherothrombosis. Archives of Internal Medicine 2010, 170:1892-1899.
    • (2010) Archives of Internal Medicine , vol.170 , pp. 1892-1899
    • Roussel, R.1    Travert, F.2    Pasquet, B.3
  • 3
    • 1642523851 scopus 로고    scopus 로고
    • Collagen cross-link breakers: A beginning of a new era in the treatment of cardiovascular changes associated with aging, diabetes, and hypertension
    • Susic D., Varagic J., Ahn J., Frohlich E.D. Collagen cross-link breakers: A beginning of a new era in the treatment of cardiovascular changes associated with aging, diabetes, and hypertension. Current Drug Targets - Cardiovascular & Haematological Disorders 2004, 4:97-101.
    • (2004) Current Drug Targets - Cardiovascular & Haematological Disorders , vol.4 , pp. 97-101
    • Susic, D.1    Varagic, J.2    Ahn, J.3    Frohlich, E.D.4
  • 4
    • 77956621295 scopus 로고    scopus 로고
    • Metabolic memory and diabetic nephropathy: Potential role for epigenetic mechanisms
    • Tonna S., El-Osta A., Cooper M.E., Tikellis C. Metabolic memory and diabetic nephropathy: Potential role for epigenetic mechanisms. Nature Reviews Nephrology 2010, 6:332-341.
    • (2010) Nature Reviews Nephrology , vol.6 , pp. 332-341
    • Tonna, S.1    El-Osta, A.2    Cooper, M.E.3    Tikellis, C.4
  • 6
    • 21044443182 scopus 로고    scopus 로고
    • Diabetic vascular complications: Pathophysiology, biochemical basis and potential therapeutic strategy
    • Yamagishi S., Imaizumi T. Diabetic vascular complications: Pathophysiology, biochemical basis and potential therapeutic strategy. Current Pharmaceutical Design 2005, 11:2279-2299.
    • (2005) Current Pharmaceutical Design , vol.11 , pp. 2279-2299
    • Yamagishi, S.1    Imaizumi, T.2
  • 7
    • 48249151077 scopus 로고    scopus 로고
    • Agents that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: A novel therapeutic strategy for diabetic vascular complications
    • Yamagishi S., Nakamura K., Matsui T., et al. Agents that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: A novel therapeutic strategy for diabetic vascular complications. Expert Opinion on Investigational Drugs 2008, 17:983-996.
    • (2008) Expert Opinion on Investigational Drugs , vol.17 , pp. 983-996
    • Yamagishi, S.1    Nakamura, K.2    Matsui, T.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.